
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
In November 2004, the British government announced a comprehensive campaign to address major health threats to the country's population. Their efforts raise a question: Where does the role of the physician stop and the responsibility of society begin?






